2025
SJR Q2
JCR Q3 · 1,6
605 matched articles
SCIE
Journal detail
Cutaneous and Ocular Toxicology
- Publisher
- Taylor and Francis Ltd.
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
1556952715569535
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,471
- Quartile Q2
- H-Index 42
- Cites/doc 1,59
- Docs (3y) 142
- Cites (3y) 266
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 1,6
- 5Y JIF 1,8
- JCI 0,53
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Complementary and Alternative Medicine Q2
- Critical Care and Intensive Care Medicine Q2
- Medicine (miscellaneous) Q3
- Pharmaceutical Science Q2
- Toxicology Q3
Areas
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Ophthalmology | Toxicology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,471 | 1,6 | 1,8 | 0,53 | Q3 | 42 |
| 2024 | Q3 | Q3 | 0,41 | 1,3 | 1,5 | 0,47 | Q3 | 39 |
| 2023 | Q3 | Q3 | 0,457 | 1,6 | 1,7 | 0,54 | Q3 | 39 |
| 2022 | Q3 | Q4 | 0,408 | 1,6 | 1,6 | 0,55 | Q3 | 39 |
| 2021 | Q3 | Q3 | 0,366 | 2 | 1,7 | 0,57 | Q3 | 39 |
| 2020 | Q3 | Q4 | 0,362 | 1,8 | 1,6 | 0,56 | Q3 | 39 |
| 2019 | Q3 | Q3 | 0,429 | 1,4 | 1,3 | 0,52 | Q3 | 39 |
| 2018 | — | Q4 | — | 1,1 | 1 | 0,35 | Q4 | — |
| 2017 | Q3 | Q4 | 0,392 | 0,9 | 1 | 0,42 | Q3 | 39 |
| 2016 | Q3 | Q4 | 0,385 | 1,2 | 1 | — | — | 39 |
| 2015 | Q3 | Q4 | 0,324 | 1,1 | 1 | — | — | 39 |
| 2014 | Q3 | Q3 | 0,296 | 1,1 | 0,9 | — | — | 39 |
| 2013 | Q3 | Q4 | 0,347 | 0,9 | 1 | — | — | 39 |
| 2012 | Q2 | Q3 | 0,368 | 1 | 1 | — | — | 39 |
| 2011 | Q3 | Q4 | 0,312 | 0,9 | 1 | — | — | 39 |
| 2010 | Q2 | Q3 | 0,343 | 0,9 | 0,9 | — | — | 39 |
| 2009 | — | Q4 | — | 1,1 | 0,9 | — | — | — |
| 2008 | — | Q4 | — | 0,6 | 0,5 | — | — | — |
| 2007 | — | Q4 | — | 0,4 | 0,4 | — | — | — |
| 2006 | — | Q4 | — | 0,3 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | OPHTHALMOLOGY | SCIE | Q3 | Q3 | 63/98 |
| 2025 | TOXICOLOGY | SCIE | Q4 | Q3 | 95/106 |
| 2024 | OPHTHALMOLOGY | SCIE | Q3 | Q3 | 65/99 |
| 2024 | TOXICOLOGY | SCIE | Q4 | Q4 | 97/106 |
| 2023 | OPHTHALMOLOGY | SCIE | Q3 | Q3 | 57/95 |
| 2023 | TOXICOLOGY | SCIE | Q4 | Q3 | 90/106 |
| 2022 | OPHTHALMOLOGY | SCIE | Q4 | Q3 | 50/62 |
| 2022 | TOXICOLOGY | SCIE | Q4 | Q4 | 90/94 |
| 2021 | OPHTHALMOLOGY | SCIE | Q3 | Q3 | 46/62 |
| 2021 | TOXICOLOGY | SCIE | Q4 | Q3 | 85/94 |
| 2020 | OPHTHALMOLOGY | SCIE | Q4 | Q3 | 49/62 |
| 2020 | TOXICOLOGY | SCIE | Q4 | Q4 | 87/93 |
| 2019 | OPHTHALMOLOGY | SCIE | Q3 | Q3 | 44/60 |
| 2019 | TOXICOLOGY | SCIE | Q4 | Q4 | 87/92 |
| 2018 | OPHTHALMOLOGY | SCIE | Q4 | Q4 | 53/60 |
| 2018 | TOXICOLOGY | SCIE | Q4 | Q4 | 90/93 |
| 2017 | OPHTHALMOLOGY | SCIE | Q4 | Q3 | 55/59 |
| 2017 | TOXICOLOGY | SCIE | Q4 | Q4 | 92/94 |
| 2016 | OPHTHALMOLOGY | SCIE | Q4 | — | 48/59 |
| 2016 | TOXICOLOGY | SCIE | Q4 | — | 85/92 |
| 2015 | OPHTHALMOLOGY | SCIE | Q4 | — | 44/56 |
| 2015 | TOXICOLOGY | SCIE | Q4 | — | 80/90 |
| 2014 | OPHTHALMOLOGY | SCIE | Q3 | — | 42/57 |
| 2014 | TOXICOLOGY | SCIE | Q4 | — | 76/88 |
| 2013 | OPHTHALMOLOGY | SCIE | Q4 | — | 49/58 |
| 2013 | TOXICOLOGY | SCIE | Q4 | — | 78/87 |
| 2012 | OPHTHALMOLOGY | SCIE | Q3 | — | 43/59 |
| 2012 | TOXICOLOGY | SCIE | Q4 | — | 72/85 |
| 2011 | OPHTHALMOLOGY | SCIE | Q4 | — | 45/58 |
| 2011 | TOXICOLOGY | SCIE | Q4 | — | 74/83 |
| 2010 | OPHTHALMOLOGY | SCIE | Q3 | — | 42/56 |
| 2010 | TOXICOLOGY | SCIE | Q4 | — | 73/83 |
| 2009 | OPHTHALMOLOGY | SCIE | Q4 | — | 37/49 |
| 2009 | TOXICOLOGY | SCIE | Q4 | — | 65/77 |
| 2008 | OPHTHALMOLOGY | SCIE | Q4 | — | 44/48 |
| 2008 | TOXICOLOGY | SCIE | Q4 | — | 68/75 |
| 2007 | OPHTHALMOLOGY | SCIE | Q4 | — | 43/45 |
| 2007 | TOXICOLOGY | SCIE | Q4 | — | 71/73 |
| 2006 | OPHTHALMOLOGY | SCIE | Q4 | — | 43/45 |
| 2006 | TOXICOLOGY | SCIE | Q4 | — | 75/76 |